The In vitro and In vivo Effects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases Catherine A. Rugg, Robert H. Gruninger, et al. Cancer Res 2005;65:9038-9046
Preclinical profile of JNJ-7706621: A dual cyclin dependent kinase and aurora kinase inhibitor Stuart L. Emanuel,et al. Proc Amer Assoc Cancer Res. 2006;47
Evaluation of the CDK inhibitor JNJ-7706621 as a targeted antitumor agent Stuart L. Emanuel,et al. Proc Amer Assoc Cancer Res. 2004;45
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.